Excitotoxins pp 122-137 | Cite as

The Neurodegenerative Properties of Intracerebral Quinolinic Acid and its Structural Analog Cis-2,3-Piperidine Dicarboxylic Acid

  • Robert Schwarcz
  • William O. WhetsellJr.
  • Alan C. Foster
Part of the Wenner-Gren Center International Symposium Series book series (WGCISS)


Experiments using intracerebral injections in rodents of kainic (KA) or ibotenic (IBO) acid, two amino acids of plant and fungal origin, respectively, have led to the hypothesis that human neurodegenerative diseases, e.g. Huntington’s disease (HD) and temporal lobe epilepsy, may be related to a pathological overproduction of endogenous neuroexcitatory amino acids (Coyle et al., 1977; Divac, 1977; Olney and de Gubareff, 1978; French et al., 1982). Of these, glutamate, aspartate and cysteine sulfinate, all putative neurotransmitters in the central nervous system (Roberts et al., 1981; Recasens et al., 1982), do not appear to posses pronounced neurotoxicity, even when introduced into the brain at very high concentrations (Olney and de Gubareff, 1978; Mangano and Schwarcz, 1983). Also, examinations of acidic amino acids in tissues and body fluids of patients suffering from HD or epilepsy have merely yielded equivocal results (Perry et al., 1975; Gray et al., 1980; Perry and Hansen, 1981; Mangano and Schwarcz, 1981, 1982). Their dysfunction in neuro-psychiatric disorders has as yet not been established.


Temporal Lobe Epilepsy Glutamate Uptake Quinolinic Acid Kynurenine Pathway Needle Track 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andersson, K., R. Schwarcz and K. Fuxe (1980): Nature, 283:94–96.PubMedCrossRefGoogle Scholar
  2. Ben-Ari, Y., J. Lagowska, E. Tremblay and G. Le Gal La Salle (1979): Brain Res., 163:176–180.PubMedCrossRefGoogle Scholar
  3. Ben-Ari, Y., E. Tremblay and O.P. Ottersen (1980): Neuroscience, 5:515–528.PubMedCrossRefGoogle Scholar
  4. Biziere, K. and J.T. Coyle (1978): Neurosci. Lett., 8:303–310.PubMedCrossRefGoogle Scholar
  5. Bruyn, G. (1968); In: Handbook of Clinical Neurology, Vol. 6 (P.J. Vinken and G. W. Bruyn, eds.), pp. 298–378, North-Ho11and, Amsterdam.Google Scholar
  6. Bull, G. and B. Oderfeld-Novak (1971): J. Neurochem., 19:935–947.CrossRefGoogle Scholar
  7. Campochiaro, P. and J.T. Coyle (1978); Proc. Natl. Acad. Sci. (USA), 75:2025–2029.CrossRefGoogle Scholar
  8. Coyle, J.T. and R. Schwarcz (1976): Nature, 263:244–246.PubMedCrossRefGoogle Scholar
  9. Coyle, J.T., R. Schwarcz, J.P. Bennett and P. Campochiaro (1977): Progr. Neuro-Psychopharmac., 1:13–30.CrossRefGoogle Scholar
  10. Coyle, J.T., R. Zaczek, J. Slevin and J. Collins (1981): In: Glutamate as a Neurotransmitter (G. Di Chiara and G.L. Gessa, eds.), pp. 337–346, Raven, New York.Google Scholar
  11. Croucher, M.J., J.F. Collins and B.S. Meldrum (1982): Science, 216:899–901.PubMedCrossRefGoogle Scholar
  12. Di Chiara, G., M.L. Porceddu, W. Fratta and G.L. Gessa (1977): Mature, 267:270–272.CrossRefGoogle Scholar
  13. Divac, I. (1977): Acta Neurol. Scand., 56:357–360.PubMedCrossRefGoogle Scholar
  14. Fagg, E.G., A.C. Foster, E.E. Mena and C.W. Cotman (1982): J. Neurosci., 2:958–965.PubMedGoogle Scholar
  15. Falconer, M.A. (1974): Lancet, 2:767–770.PubMedCrossRefGoogle Scholar
  16. Foster, A.C. and P.J. Roberts (1978): J. Neurochem., 31:1476–1477.CrossRefGoogle Scholar
  17. French, E.D., C. Aldinio and R. Schwarcz (1982): Neuroscience, in press.Google Scholar
  18. Gal, E.M. (1974): J. Neurochem., 22:861–863.PubMedCrossRefGoogle Scholar
  19. Gal, E.M. and A.D. Sherman (1978): J. Neurochem., 30:607–613.PubMedCrossRefGoogle Scholar
  20. Gholson, R.K., I. Ueda, N. Ogasawa and L.M. Henderson (1964): J. Biol. Chem., 239: 1208–1214.PubMedGoogle Scholar
  21. Gray, P.N., P.C. May, L. Mundy and J. Elkins (1980): Biochem. Biophys. Res. Comm., 95:707–714.PubMedCrossRefGoogle Scholar
  22. Hattori, T. and E.G. McGeer (1977): Brain Res., 129:174–180.PubMedCrossRefGoogle Scholar
  23. Henderson, L.M. and G.B. Ramasarma (1949): J. Biol. Chem., 181:687–692.PubMedGoogle Scholar
  24. Köhler, C. and R. Schwarcz (1981): Int. Soc. Neurochem. Abstr., p. 272.Google Scholar
  25. Köhler, C., R. Schwarcz and K. Fuxe (1979a): Neurosci. Lett., 15:223–228.PubMedCrossRefGoogle Scholar
  26. Köhler, C., R. Schwarcz and K. Fuxe (1979b): Brain Res., 175:366–371.PubMedCrossRefGoogle Scholar
  27. König, J.F.R. and R.A. Klippel (1963): The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brainstem, Williams and Wilkins, Baltimore.Google Scholar
  28. Lapin, I.P. (1978): J. Neural Transm., 42:37–43.PubMedCrossRefGoogle Scholar
  29. Mangano, R.M. and R. Schwarcz (1981): J. Neurochem., 37:1072–1074.PubMedCrossRefGoogle Scholar
  30. Mangano, R.M. and R. Schwarcz (1982): J. Neurol. Sci., 53:489–500.PubMedCrossRefGoogle Scholar
  31. Mangano, R.M. and R. Schwarcz (1983): Brain Res. Bull., in press.Google Scholar
  32. Maxwell, J.R. and P.D. Ray (1980): Biochim. Biophys. Acta, 614:163–172.Google Scholar
  33. McGeer, E.G. and P.L. McGeer (1976): Nature, 263:517–519.PubMedCrossRefGoogle Scholar
  34. McGeer, E.G., P.L. McGeer and K. Singh. (1978): Brain Res., 139:381–383.PubMedCrossRefGoogle Scholar
  35. Mena, E.E., G.E. Fagg and C.W. Cotman (1982): Brain Res., 243:378–381.PubMedCrossRefGoogle Scholar
  36. Menini, C., B.S. Meldrum, D. Riche, C. Silva-Comte and J.M. Stutzmann (1980): Ann. Neurol., 8:501–509.PubMedCrossRefGoogle Scholar
  37. Nadler, J.V., D.A. Evenson and G.L. Cuthbertson (1981): Neuroscience, 6:2505–2517.PubMedCrossRefGoogle Scholar
  38. Nadler, J.V., B.W. Perry and C.W. Cotman (1978): Nature, 271:676–677.PubMedCrossRefGoogle Scholar
  39. Olney, J.W. (1978): In: Kainic Acid as a Tool in Neurobiology (E.G. McGeer, J.W. Olney and P.L. McGeer, eds.), pp. 95–121, Raven, New York.Google Scholar
  40. Olney, J.W. (1980): In: Experimental and Clinical Neurotoxicity (P.S. Spencer and H.H. Schaumburg, eds.), pp. 272–294, Williams and Wilkins, Baltimore.Google Scholar
  41. Olney, J.W. and T. de Gubareff (1978): Nature, 271:557–559.PubMedCrossRefGoogle Scholar
  42. Olney, J.W., O.H. Ho and V. Rhee (1971): Exp. Brain Res., 14:61–76.PubMedCrossRefGoogle Scholar
  43. Perry, T.L. and S. Hansen (1981): Neurobiology, 31:872–876.Google Scholar
  44. Perry, T.L., S. Hansen, J. Kennedy, J.A. Wada and G.B. Thompson (1975): Arch. Neurol., 32:752–754.PubMedCrossRefGoogle Scholar
  45. Recasens, M., T.V. Varga, D. Nanopoulos, F. Saadoun, G. Vincendon and J. Benavides (1982): Brain Res., 239:153–173.PubMedCrossRefGoogle Scholar
  46. Roberts, P.J., J. Storm-Mathisen and G.A.R. Johnston (1981): Glutamate: Transmitter in the Central Nervous System, Wiley, New York.Google Scholar
  47. Schwarcz, R., J.F. Collins and D.A. Parks (1982b): Neurosci. Lett., in press.Google Scholar
  48. Schwarcz, R. and J.T. Coyle (1977): Life Sci., 20:431–436.PubMedCrossRefGoogle Scholar
  49. Schwarcz, R. and K. Fuxe (1979): Life Sci., 24:1471–1480.PubMedCrossRefGoogle Scholar
  50. Schwarcz, R., T. Hökfelt, K. Fuxe, G. Jonsson, M. Goldstein and L. Terenius (1979): Exp. Brain Res., 37:199–216.PubMedCrossRefGoogle Scholar
  51. Schwarcz, R., D. Scholz and J.T. Coyle (1978a): Neuropharmac., 17:145–151.CrossRefGoogle Scholar
  52. Schwarcz, R., W.O. Whetsell, Jr. and R.M. Mangano (1982a): Science, in press.Google Scholar
  53. Schwarcz, R., R. Zaczek and J.T. Coyle (1978b): Europ. J. Pharmac., 50:209–220.CrossRefGoogle Scholar
  54. Schwob, J.E., T. Fuller, J.L. Price and J.W. Olney (1980): Neuroscience, 5:991–1014.PubMedCrossRefGoogle Scholar
  55. Simon, J.R., J.F. Contrera and M.J. Kuhar (1976): J. Neurochem., 26:141–147.PubMedGoogle Scholar
  56. Stone, T.W. and M.N. Perkins (1981): Europ. J. Pharmac, 72:411–412.CrossRefGoogle Scholar
  57. Storm-Mathisen, J. (1977): Brain Res., 120:376–386.CrossRefGoogle Scholar
  58. Watkins, J.C. (1981): In: Glutamate: Transmitter in the Central Nervous System (P.J. Roberts, J. Storm-Mathisen and G.A.R. Johnston, eds.), pp. 1–25, Wiley, New York.Google Scholar
  59. Watkins, J.C. and R.H. Evans (1981): Ann. Rev. Pharmac. Toxic, 21:165–204.CrossRefGoogle Scholar
  60. Waymire, J.C., R. Bjur and N. Weiner (1971): Anal. Biochem., 43:588–600.PubMedCrossRefGoogle Scholar
  61. Wuerthele, S.M., K.L. Lovell, M.Z. Jones and K.E. Moore (1978): Brain Res., 149: 489–497.PubMedCrossRefGoogle Scholar

Copyright information

© The Wenner-Gren Center 1983

Authors and Affiliations

  • Robert Schwarcz
    • 1
  • William O. WhetsellJr.
    • 2
  • Alan C. Foster
    • 1
  1. 1.Maryland Psychiatric Research CenterUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.Division of NeuropathologyUniversity of Tennessee Center of the Health SciencesMemphisUSA

Personalised recommendations